NCT01693211

Brief Summary

This is a prospective, randomized study evaluating the circularity of the anterior capsulotomy performed by the VICTUS femtosecond work station (Group A) versus the manual capsulotomy (Group B) of a minimum of 22 eyes and maximum of 30 eyes per group diagnosed with cataract, scheduled to undergo removal by phacoemulsification with intraocular lens implantation in SNEC. The primary study end point is to determine if the circularity of the created rhexis is better in Group A as compared to Group B. The secondary study end point is to determine the diameter of rhexis is more precise and reproducible in Group A as compared to Group B.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
48

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Sep 2012

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2012

Completed
13 days until next milestone

First Submitted

Initial submission to the registry

September 14, 2012

Completed
12 days until next milestone

First Posted

Study publicly available on registry

September 26, 2012

Completed
1.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2014

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2014

Completed
Last Updated

July 1, 2014

Status Verified

June 1, 2014

Enrollment Period

1.7 years

First QC Date

September 14, 2012

Last Update Submit

June 30, 2014

Conditions

Keywords

femtosecond lasercataractcontrol studyprospective

Outcome Measures

Primary Outcomes (1)

  • Circularity of created rhexis

    The primary study end point is to determine if the circularity of the created rhexis is better in Group A as compared to Group B. On the day of surgery immediately after the creation of the rhexis via an recorded surgical video.

    intraoperative

Secondary Outcomes (1)

  • Diameter of the created rhexis

    intraoperative

Other Outcomes (1)

  • Centration of the created rhexis relative to the pupil

    surgery day, 1-Day, 1-week, 1-Month

Study Arms (2)

Group A

EXPERIMENTAL

Capsulorhexis and pre-fragmentation of the nucleus are performed by the femtosecond laser.

Device: Femtosecond Laser (VICTUS™ Femtosecond Laser Platform)

Group B

ACTIVE COMPARATOR

The Capulorhexis and nuclear fragmentation are performed manually.

Device: Manual (CCC technique with Utrata forceps)

Interventions

Capsulotomy and pre-fragmentation of the nucleus are performed by the femtosecond laser.

Group A

Capsulorhexis and pre-fragmentation are performed manually.

Group B

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Consenting patients undergoing phacoemulsification and IOL implant surgery for cataract, the diagnosis of which has been confirmed by another investigator.
  • Clear cornea media
  • Pupil must be able to dilate to at least 6mm in diameter measured with the pupil gauge

You may not qualify if:

  • Pre-existing posterior capsule rupture Difference between maximum and minimum K-values must not be more than 5 D. The maximum K- value may not exceed 60 D and the minimal value may not be smaller than 37 D.
  • Corneal disease or pathology that precludes transmission of laser wavelength or distortion of laser light.
  • Subjects with a poorly dilating pupil or other defect of the pupil that prevents the iris from adequate retraction peripherally.
  • Lens/zonular instability such as, but not restricted to, Marfan's Syndrome, Pseudoexfoliation Syndrome, etc.
  • Previous intraocular or corneal surgery of any kind, including any type of surgery for either refractive or therapeutic purposes in either eye.
  • Patients with disorders of the ocular muscle, such as nystagmus or strabismus Keratoconus
  • ACD \< 1.8 mm or ACD \> 4.5 mm

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Singapore National Eye Centre

Singapore, Singapore, 168751, Singapore

Location

Related Links

MeSH Terms

Conditions

Cataract

Condition Hierarchy (Ancestors)

Lens DiseasesEye Diseases

Study Officials

  • Soon Phaik Chee, Assoc Prof

    Singapore National Eye Center

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 14, 2012

First Posted

September 26, 2012

Study Start

September 1, 2012

Primary Completion

June 1, 2014

Study Completion

June 1, 2014

Last Updated

July 1, 2014

Record last verified: 2014-06

Locations